Proprietary Notice

General Terms: Optum Inc., and/or one of its subsidiaries and/or affiliates (“Optum”) is the owner/licensor of InterQual^® and InterQual^® Connect products, including the clinical content (“Clinical Content”) software and SaaS services used to deliver the solutions (collectively the “Solutions”). The Solutions contain confidential and trade secret information of Optum and is provided to licensees who have an existing license agreement in force only under the time-limited license as provided under that license agreement. Licensee and any recipient thereunder shall use the Solutions in accordance with the terms and conditions of the license agreement.

Proprietary Notice: The Solutions are protected under United States and international copyright and other intellectual property laws. If the Solutions are delivered pursuant to a federal government contract that requires the conveyance of rights in data to the government, it is understood that the Solutions, including commercial software, clinical content, third-party software, documentation and/or other technical data, were developed exclusively at Optum’s private expense, and that Optum will convey only limited or restricted rights in the Solutions to the government consistent with the guidance set forth in the Federal Acquisition Regulation (“FAR”) and/or FAR Supplements. Conveyance of any additional rights beyond limited or restricted rights in the Solutions requires Optum’s express consent contained in a separate written agreement.

No portion of this publication may be copied, reproduced, or incorporated into any other media without Optum’s prior written consent.

Acknowledgments and Disclaimer: The Clinical Content is developed by Optum’s clinical research staff which includes physicians, registered nurses, and other healthcare professionals. Many of Optum's clinical staff hold advanced degrees and case management certification. The Clinical Content is reviewed and validated by a national panel of clinicians and medical experts, including those in community and academic practice settings, as well as within the managed care industry throughout the United States. The Clinical Content is a synthesis of evidence-based standards of care, current practices, and consensus from licensed specialists and/or primary care physicians.

The Clinical Content reflects clinical interpretations and analyses and cannot alone either resolve medical ambiguities of particular situations or provide the sole basis for definitive decisions. The Clinical Content is intended solely for use as screening guidelines with respect to the medical appropriateness of healthcare services and not for final clinical or payment determinations concerning the type or level of medical care provided, or proposed to be provided, to a patient.

THE SOLUTIONS ARE PROVIDED “AS IS.” OPTUM DISCLAIMS ANY OTHER WARRANTY, EXPRESS OR IMPLIED, INCLUDING AS TO MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR SERVICE OF THE SOLUTIONS, OR THE COMPATIBILITY OF OUTPUT USING THE SOLUTIONS WITH ANY LAW, REGULATION, OR ORDER. IN NO EVENT SHALL OPTUM BE LIABLE FOR SPECIAL, INCIDENTAL, CONSEQUENTIAL, OR EXEMPLARY DAMAGES IN CONNECTION WITH, OR ARISING OUT OF, ANY USE OF EITHER OR BOTH OF THE SOLUTIONS.

Third Party Notices:

AMA CPT® Codes: The Solutions may incorporate the CPT® terminology developed and copyrighted by the American Medical Association (“AMA”). The CPT codes and terminology are provided pursuant to a license agreement between Change Healthcare, LLC and/or one of its affiliates or subsidiaries, and the AMA.

CPT copyright 2013-2024 American Medical Association. All rights reserved. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein. CPT is a registered trademark of the American Medical Association. Applicable FARS/DFARS Restrictions Apply to Government Use.

BCBSA MPRM: The BCBSA Medical Policy Reference Manual (MPRM) is the proprietary and confidential information of Blue Cross Blue Shield Association. © 2001-2024 Blue Cross Blue Shield Association. All Rights Reserved. The MPRM content is licensed to Change Healthcare, LLC and/or one of its affiliates or subsidiaries.

NCCN Compendium: © National Comprehensive Cancer Network, Inc 2011-2024, All Rights Reserved. NATIONAL COMPREHENSIVE CANCER NETWORK®, NCCN^®, NCCN GUIDELINES^®, NCCN TEMPLATES^®, and NCCN COMPENDIUM^® are trademarks owned by the National Comprehensive Cancer Network, Inc.

ASAM Criteria: The ASAM Criteria, Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions, the Third Edition. Copyright © 2013-2024 American Society of Addiction Medicine (ASAM).

ASAM Criteria: The ASAM Criteria, Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions, Fourth Edition. Copyright © 2023-2024 American Society of Addiction Medicine (ASAM).

U.S. Government Rights

The Solutions may include CPT which is commercial technical data and/or computer data bases and/or commercial computer software and/or commercial computer software documentation, as applicable, which was developed exclusively at private expense by the American Medical Association, AMA Plaza, 330 North Wabash, Suite 39300, Chicago, Illinois, 60611-5885. U.S. Government rights to use, modify, reproduce, release, perform, display, or disclose these technical data and/or computer data bases and/or computer software and/or computer software documentation are subject to the limited rights restrictions of DFARS 252.227-7015(b)(2) (November 1995) and/or subject to the restrictions of DFARS 227.7202-1(a) (June 1995) and DFARS 227.7202-3(a) (June 1995), as applicable, for U.S. Department of Defense procurements and the limited rights restrictions of FAR 52.227-14 (December 2007) and/or subject to the restricted rights provisions of FAR 52.227-14 (December 2007) and FAR 52.227-19 (December 2007), as applicable, and any applicable agency FAR Supplements, for non-Department of Defense Federal procurements.